Pages that link to "Q74366561"

The following pages link to Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells (Q74366561):

Displaying 44 items.

• Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription (Q24336095) (← links)
• Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4. (Q24537669) (← links)
• Feedback inhibition by RALT controls signal output by the ErbB network (Q28183228) (← links)
• PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling (Q28253621) (← links)
• Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data (Q28469088) (← links)
• Cyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesis (Q28749707) (← links)
• EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation (Q33258056) (← links)
• Expression and function of heregulin-α and its receptors in the mouse mammary gland (Q33686043) (← links)
• Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression (Q34948119) (← links)
• Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts (Q35028823) (← links)
• Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts (Q35031049) (← links)
• SN50 enhances the effects of LY294002 on cell death induction in gastric cancer cell line SGC7901. (Q35086606) (← links)
• Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. (Q35540734) (← links)
• Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. (Q35568967) (← links)
• Reduced levels of ATF-2 predispose mice to mammary tumors. (Q35676210) (← links)
• Correlation between p38 mitogen-activated protein kinase and human telomerase reverse transcriptase in sarcomas (Q35811955) (← links)
• Integrated analysis reveals that STAT3 is central to the crosstalk between HER/ErbB receptor signaling pathways in human mammary epithelial cells (Q35966355) (← links)
• A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells (Q36195594) (← links)
• Roles for neuregulins in human cancer. (Q36202795) (← links)
• The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells (Q36407783) (← links)
• Vitamin E and apoptosis (Q36880053) (← links)
• Joint requirement for Rac and ERK activities underlies the mid-G1 phase induction of cyclin D1 and S phase entry in both epithelial and mesenchymal cells (Q36957805) (← links)
• Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway (Q37220791) (← links)
• Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice (Q37402452) (← links)
• HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4). (Q37407344) (← links)
• Signal integration by JNK and p38 MAPK pathways in cancer development (Q37560607) (← links)
• Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo (Q37728776) (← links)
• When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase (Q38673589) (← links)
• EGFR signaling pathways are wired differently in normal 184A1L5 human mammary epithelial and MDA-MB-231 breast cancer cells. (Q38709632) (← links)
• Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo (Q38712735) (← links)
• Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase (Q38796484) (← links)
• Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1. (Q40000114) (← links)
• A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates (Q40443775) (← links)
• Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization. (Q40479165) (← links)
• Gene expression profiling of ErbB receptor and ligand-dependent transcription (Q40587910) (← links)
• Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro (Q40643553) (← links)
• Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma (Q44744096) (← links)
• Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins (Q44872922) (← links)
• p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation (Q47677865) (← links)
• p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines (Q48144894) (← links)
• Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance. (Q55071512) (← links)
• Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease (Q59798268) (← links)
• RETRACTED: TRPV6 calcium channel regulation, downstream pathways, and therapeutic targeting in cancer (Q91761566) (← links)
• TRPV6 as A Target for Cancer Therapy (Q92383138) (← links)